ICD-10-CM Billable Code

C50.512

Malignant neoplasm of lower-outer quadrant of left female breast

Clinical Classification Guidelines

Medical Intelligence & Overview

The diagnosis with ICD-10 code C50.512 refers to a malignant tumor located in the lower-outer part of the left female breast. This type of breast cancer originates from the cells of the milk-producing ducts or lobules. Recognizing the specifics of this diagnosis helps in understanding the condition's implications, potential treatment options, and prognosis. Early detection and tailored treatment strategies are crucial for improving outcomes.

Causes & Symptoms

Clinical Causes: Genetic factors, such as mutations in BRCA1 and BRCA2 genes Hormonal influences, including prolonged exposure to estrogen Family history of breast cancer Lifestyle factors like alcohol consumption, smoking, and obesity Previous history of radiation therapy to the chest area Age, with higher risk observed in women over 50

Key Symptoms: A lump or thickening in the lower-outer quadrant of the breast Changes in the size, shape, or appearance of the breast Skin changes over the affected area, such as dimpling or redness Nipple alterations, including inversion or discharge Persistent pain in the breast or nipple area Feeling of heaviness or fullness in the breast

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a combination of clinical examination, imaging tests, and biopsy procedures. The following steps are commonly employed: - Mammography: To detect and evaluate abnormal areas within the breast tissue. - Ultrasound: Assists in differentiating between cystic and solid masses. - MRI: Used in certain cases for detailed imaging. - Biopsy: The definitive method for diagnosing malignancy by examining tissue samples microscopically. Further tests might include hormonal receptor testing and genetic profiling to guide treatment options.

Treatment Protocols: Treatment strategies depend on the tumor's stage, receptor status, and overall health of the patient. - Surgery: Usually involves lumpectomy or mastectomy to remove the tumor. - Radiation Therapy: Often used post-surgery to eradicate residual cancer cells. - Chemotherapy: Utilized to target cancer cells systemically, especially in advanced stages. - Hormone Therapy: Applicable if the tumor is hormone receptor-positive. - Targeted Therapy: Drugs that specifically target cancer cell mechanisms might be recommended. - Follow-up Care: Regular monitoring for recurrence or metastasis is essential, involving clinical exams and imaging.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is C50.512 a billable ICD-10 code?
Yes, C50.512 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report C50.512?
Clinical documentation must specify the nature of Malignant neoplasm of lower-outer quadrant of left female breast and any associated comorbidities for accurate reporting.

Cite this Clinical Reference